S Borchmann
Overview
Explore the profile of S Borchmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
30
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brockelmann P, Muller H, Fuchs M, Gillessen S, Eichenauer D, Borchmann S, et al.
Ann Oncol
. 2024 Dec;
PMID: 39706337
Background: This study aimed to evaluate the correlation between progression-free (PFS) and overall survival (OS) after first-line treatment of classical Hodgkin lymphoma (HL) and to assess the potential of PFS...
2.
Delahousse J, Wagner A, Borchmann S, Adjei A, Haanen J, Burgers F, et al.
ESMO Open
. 2024 Dec;
9(12):104002.
PMID: 39662226
Background: In addition to the effect of body weight, a patient's sex can influence the pharmacokinetics (PK) of anticancer agents, and thereby their activity and safety. The magnitude and relevance...
3.
Ozdemir B, Oertelt-Prigione S, Adjei A, Borchmann S, Haanen J, Letsch A, et al.
Ann Oncol
. 2022 Jan;
33(2):126-128.
PMID: 35058112
No abstract available.
4.
Goereci Y, Schweitzer F, Wellstein A, Silling S, Borchmann S, von Tresckow B, et al.
Eur J Neurol
. 2020 Jul;
27(11):2375-2377.
PMID: 32644211
No abstract available.
5.
Borchmann S, Muller H, Hude I, Fuchs M, Borchmann P, Engert A
Ann Oncol
. 2019 May;
30(8):1329-1334.
PMID: 31132094
Background: The prognosis of Hodgkin lymphoma (HL) is excellent rendering research into treatment complications highly important. An important complication of cancer and its treatment is thrombosis. Thrombotic events are regularly...